GlassScriptPhysician profile
George P Mitchell
NPI 1386938884
$2,176.32
in general payments reported to CMS, 2019-2025
16 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.39 · 2023: $22.31 · 2024: $947 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $485.18 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $449.25 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $323.96 | 2024-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $182.60 | 2021-2024 | Xarelto |
| Amgen INC. | $154.81 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $142.27 | 2024-2025 | Verquvo |
| Heartflow, INC. | $120.81 | 2025 | |
| Boston Scientific Corporation | $82.28 | 2024-2025 | Varithena Administration Pack, Watchman Flx |
| Abbvie INC. | $42.96 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.03 | 2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $34.63 | 2025 | |
| Novo Nordisk INC | $33.44 | 2021-2024 | Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $23.85 | 2021 | |
| Pfizer INC. | $21.49 | 2025 | |
| Esperion Therapeutics, INC. | $20.08 | 2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.68 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.